Posted on 8/9/16
Check-Cap Ltd. Announces $5.9 Million Financing
Check-Cap Ltd. (NASDAQ: CHEK, CHEKW), a clinical stage medical diagnostics company engaged in the development of an ingestible capsule for preparation-free, colorectal cancer screening, today announced that . . .
Posted on 8/9/16
IDEXX Laboratories to Host 2016 Investor Day
IDEXX Laboratories, Inc. (NASDAQ: IDXX) will host its 2016 Investor Day on August 17-18, 2016 at its corporate headquarters in Westbrook, Maine. A live audio webcast . . .
Posted on 8/9/16
Charles River Laboratories Announces Partnership with the Milner Therapeutics Institute and Consortium
WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) today announced that it has entered into a strategic partnership with the Milner Therapeutics Institute and Consortium.The . . .
Posted on 8/9/16
Navidea Executes a Term Sheet with Cerveau Technologies
DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB) announces the execution of a non-binding term sheet with Cerveau Technologies, Inc. (Cerveau) of Boston, MA sublicensing the . . .
Posted on 8/8/16
Personal Genome Diagnostics To Collaborate With Illumina
Personal Genome Diagnostics Inc. (PGDx), a leading provider of advanced cancer genome testing products and services, today announced an agreement with Illumina, Inc. (NASDAQ: ILMN) to . . .
Posted on 8/8/16
Alkermes Submits Supplemental New Drug Application to FDA for Two-Month Dosing Option of ARISTADA for Treatment of Schizophrenia
DUBLIN--(BUSINESS WIRE)--Alkermes plc (NASDAQ: ALKS) today announced that it has submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for . . .
Posted on 8/8/16
SCYNEXIS Reports Second Quarter 2016 Financial Results and Provides Company Update
JERSEY CITY, N.J., Aug. 08, 2016 (GLOBE NEWSWIRE) -- Drug development company SCYNEXIS, Inc. (Nasdaq:SCYX), a pharmaceutical company developing novel anti-infectives, today reported financial results for . . .
Posted on 8/8/16
GBMC’s Comprehensive Obesity Management Program Receives National Accreditation
Greater Baltimore Medical Center’s Comprehensive Obesity Management Program (COMP) recently received an earned certification for weight loss surgery under the Metabolic and Bariatric Surgery Accreditation and . . .
Posted on 8/8/16
David Gutwald Joins Independent Living Systems as SVP of Operations
Independent Living Systems (ILS) is pleased to announce that David Gutwald has joined the organization to serve as Senior Vice President of Operations. In this role, . . .
Posted on 8/8/16
April Cole Joins Independent Living Systems as Vice President of Sales
Independent Living Systems (ILS) is pleased to announce that April Cole has joined the organization to serve as the company’s Vice President of Sales. In this . . .
Posted on 8/8/16
CBCC Adds Critical Blood Drives Around Charlotte Region to Ensure Adequate Patient Needs
The Community Blood Center of the Carolinas (CBCC) needs blood donors to help ensure blood availability for local patients. CBCC has added additional weekly community blood . . .
Posted on 8/8/16
Celgene and Novartis Lift Juno Therapeutics' Q2 Results
IMAGE SOURCE: GETTY IMAGES.Owning a clinical-stage biotech stock can sometimes be like riding a roller coaster. Juno Therapeutics (NASDAQ:JUNO) shareholders have gotten to experience how apt . . .
Posted on 8/8/16
3 Biotech Stocks to Buy in August
IMAGE SOURCE: GETTY IMAGES.It's been an awful year to be a biotech shareholder. The market-cap-weighted iShares Nasdaq Biotechnology ETF has bounced off some scary low points . . .
Posted on 8/8/16
Puma Biotechnology's Alan Auerbach Hopes to Catch Lightning in a Bottle (Again)
After developing the top-selling prostate cancer drug Zytiga, healthcare entrepreneur Alan Auerbach sold Cougar Biotech to Johnson & Johnson for $1 billion back in 2009. Today, . . .
Posted on 8/8/16
Why Tesaro, Inc. Vaulted 15% in July
IMAGE SOURCE: GETTY IMAGES.What: After reporting success in a phase 3 ovarian cancer trial at the end of June, shares inTesaro, Inc. (NASDAQ:TSRO) spiked 15% in . . .
Posted on 8/8/16
Does Biogen's Strong Quarter Mask Underlying Weaknesses?
IMAGE SOURCE: GETTY IMAGES.Biogen (NASDAQ:BIIB) reported earnings on July 21, and the stock saw a nice (roughly 8%) gain by end of day due to beating . . .
Posted on 8/5/16
Can This Moonshot Reverse GlaxoSmithKline's Fortunes?
IMAGE SOURCE: GETTY IMAGES.Since 2012, GlaxoSmithKline (NYSE:GSK) has been quietly pioneering an entirely new scientific field: bioelectronic medicines. The basic idea is to build miniaturized implantable . . .
Posted on 8/5/16
Better Buy: Merck & Co. Inc. vs. Eli Lilly
IMAGE SOURCE: GETTY IMAGES.Over the past decade, the iShares U.S. Pharmaceuticals ETF has risen a stunning 211%, trouncing the broad market S&P 500 benchmark's gain of . . .
Posted on 8/5/16
bluebird bio Inc. Tumbles 9.4% After Reporting a Wider-Than-Expected Q2 Loss
IMAGE SOURCE: GETTY IMAGES.What: Shares of bluebird bio (NASDAQ:BLUE), a clinical-stage biotechnology company focused on the development of gene-based therapies to treat severe and/or rare genetic . . .
Posted on 8/5/16
Purdue Pharma Joins the National Pharmaceutical Council
The National Pharmaceutical Council (NPC) today announced Purdue Pharma L.P. as its newest member, and that Dr. Tracy Mayne, head of Medical Affairs Strategic Research at . . .
Posted on 8/5/16
Evolent Health Partners with St. Luke's Health Partners
Evolent Health, Inc (NYSE: EVH), and St. Luke's Health Partners announced today that they have entered into a definitive agreement for a multi-year operating partnership. The . . .
Posted on 8/5/16
Palatin Technologies Closes $9.2 Million Financing
Palatin Technologies, Inc. (NYSE MKT: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics
Posted on 8/5/16
Polaris Strategic Solutions Extends Healthcare Data Analytics Service to Community, Rural and Critical Access Hospitals
MALVERN, Pa.--(BUSINESS WIRE)--Polaris Strategic Solutions announced today that they will be introducing new brand positioning for their Polaris offering and extending their unique, customized data analytics . . .
Posted on 8/5/16
Rosetta Genomics Expands Molecular Diagnostics Test Menu with Launch of OncoGxSelect from Admera Health
PHILADELPHIA & REHOVOT, Israel--(BUSINESS WIRE)--Rosetta Genomics Ltd. (NASDAQ:ROSG), a leading developer and provider of microRNA-based and other molecular diagnostics, announces the launch of OncoGxSelect™, a next . . .
Posted on 8/5/16
Ateb Partners With iMedicare
iMedicare, the leading Medicare plan comparison software for community pharmacies, and Ateb, Inc., the industry's leading provider of pharmacy-based patient care solutions, announced today their partnership . . .

